Windtree Therapeutics, Inc.

Windtree Therapeutics, Inc.verified

WINT

Price:

$0.721

Market Cap:

$6.31M

Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart failure, as well as in Phase IIa clinical trial for the treatment of early cardiogenic shock; AEROSURF, an aerosolized KL4 surfactant, which is in Phase IIb clinical trial to treat respiratory distress syndrome in premature infants; Lyophilized KL4 surfactant, which is in Phase IIa clinical trial for the treatment of lung injury resulting from COVID-1...[Read more]

Industry

Biotechnology

IPO Date

1995-08-07

Stock Exchange

NASDAQ

Ticker

WINT

The Enterprise Value as of November 2024 (TTM) for Windtree Therapeutics, Inc. (WINT) is 8.37M

According to Windtree Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 8.37M. This represents a change of 51.54% compared to the average of 5.52M of the last 4 quarters.

Windtree Therapeutics, Inc. (WINT) Historical Enterprise Value (quarterly & annually)

How has WINT Enterprise Value performed in the past?

The mean historical Enterprise Value of Windtree Therapeutics, Inc. over the last ten years is 303.29M. The current 8.37M Enterprise Value has changed 175.90% with respect to the historical average. Over the past ten years (40 quarters), WINT's Enterprise Value was at its highest in in the December 2018 quarter at 2.89B. The Enterprise Value was at its lowest in in the June 2023 quarter at -4021000.00.

Quarterly (TTM)
Annual

Average

303.29M

Median

94.69M

Minimum

2.23M

Maximum

1.75B

Windtree Therapeutics, Inc. (WINT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Windtree Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 589.31%

Maximum Annual Enterprise Value = 1.75B

Minimum Annual Increase = -90.67%

Minimum Annual Enterprise Value = 2.23M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202315.36M589.31%
20222.23M-90.67%
202123.88M-69.85%
202079.19M-19.59%
201998.48M-75.45%
2018401.15M341.32%
201790.90M-56.03%
2016206.72M-42.88%
2015361.92M-79.36%
20141.75B-19.21%

Windtree Therapeutics, Inc. (WINT) Average Enterprise Value

How has WINT Enterprise Value performed in the past?

The current Enterprise Value of Windtree Therapeutics, Inc. (WINT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

13.82M

5-year avg

43.83M

10-year avg

303.29M

Windtree Therapeutics, Inc. (WINT) Enterprise Value vs. Peers

How is WINT’s Enterprise Value compared to its peers?

Windtree Therapeutics, Inc.’s Enterprise Value is greater than NeuroBo Pharmaceuticals, Inc. (-5104244.00), greater than Palisade Bio, Inc. (-7167243.00), greater than Lixte Biotechnology Holdings, Inc. (1.95M), greater than Avenue Therapeutics, Inc. (-1712754.00), greater than ContraFect Corporation (-1135867.00),

CompanyEnterprise ValueMarket cap
-5104244.00$22.66M
-7167243.00$3.68M
1.95M$4.54M
-1712754.00$3.21M
-1135867.00$1.72M

Build a custom stock screener for Windtree Therapeutics, Inc. (WINT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Windtree Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Windtree Therapeutics, Inc. (WINT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Windtree Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Windtree Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Windtree Therapeutics, Inc. (WINT)?

What is the 3-year average Enterprise Value for Windtree Therapeutics, Inc. (WINT)?

What is the 5-year average Enterprise Value for Windtree Therapeutics, Inc. (WINT)?

How does the current Enterprise Value for Windtree Therapeutics, Inc. (WINT) compare to its historical average?